ROYAL OAK, Mich., March 06, 2017 -- Bonal International, Inc. (OTC:BONL) has announced a dividend of $0.04 per share. This dividend marks the twentieth time Bonal has issued dividends over the last twelve consecutive fiscal years. The dividend is payable on March 28, 2017 to shareholders of record as of the close of business on March 22, 2017.
Dividends are paid out of retained earnings. The Bonal International board of directors will continue to evaluate the Company’s dividend policy on a quarterly basis.
Bonal International, Inc., through its wholly owned subsidiary, Bonal Technologies, Inc. is the patent holder and world’s leading provider of sub-harmonic vibratory stress relief and weld conditioning technology. Bonal provides three lines of equipment – Meta-Lax® Stress Relief and Weld Conditioning, Pulse Puddle Arc Welding®, and Black Magic® Distortion Control, which are sold in the United States and more than 60 countries worldwide. Headquartered in Royal Oak, Michigan, Bonal serves the aerospace, automotive, defense, die casting, machine tool building, mining, mold making, power generation, racing, shipbuilding, and welding industries. Bonal’s Meta-Lax technology is used to eliminate thermal stress in metal parts, thereby preventing warping and cracking, at a fraction of the time, energy, and monetary costs of competing technologies. More information can be found at www.Bonal.com or by calling 1-800-Meta-Lax.
Contact: Thomas E. Hebel Toll Free: 800.638.2529 ext.236 International: 248.582.0900 ext.236 Email: [email protected]


SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



